We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
-32.59%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
-$144M
Cap. Flow
-$2.36M
Cap. Flow %
-1.27%
Top 10 Hldgs %
99.89%
Holding
11
New
–
Increased
2
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$26.1M
2
SERA icon
Sera Prognostics
SERA
+$116K

Top Sells

Rank Stock Value
1
CVAC
CureVac
CVAC
+$28.5M
2
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$158K

Sector Composition

Rank Sector Weight
1 Healthcare 99.3%
2 Materials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIR icon
1
Vir Biotechnology
VIR
$1.47B
$40.1M 21.56%
1,559,142
+881,365
+130% +$26.1M
CVAC
2
DELISTED
CureVac
CVAC
$33.5M 18.01%
1,709,781
-1,424,999
-45% -$28.5M
LMDX
3
DELISTED
LumiraDx Limited Common Shares
LMDX
$33.4M 17.96%
5,574,059
– –
BNTX icon
4
BioNTech
BNTX
$22.6B
$25.4M 13.66%
148,674
– –
EXAI
5
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$22.9M 12.31%
1,590,909
– –
IMCR icon
6
Immunocore
IMCR
$1.78B
$17.2M 9.25%
576,923
– –
BFLY icon
7
Butterfly Network
BFLY
$1.72B
$4.8M 2.58%
1,011,003
– –
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$4.2M 2.26%
1,331,358
-65,286
-5% -$158K
SERA icon
9
Sera Prognostics
SERA
$80.3M
$3M 1.61%
799,814
+20,000
+3% +$116K
AMRS
10
DELISTED
Amyris Inc.
AMRS
$1.3M 0.7%
292,398
– –
ZY
11
DELISTED
Zymergen Inc. Common Stock
ZY
$200K 0.11%
59,970
– –

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q1 2022 Portfolio in Review

As of Q1 2022, Gates Foundation held 11 positions worth $186M, down 44% from $330M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Gates Foundation opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Materials.

  • Gates Foundation added most to Vir Biotechnology in Q1 2022, an estimated $26.1M increase.
  • Gates Foundation's biggest Q1 2022 reduction was CureVac, cutting an estimated $28.5M.
  • Gates Foundation's ten largest holdings make up 100% of its $186M portfolio in Q1 2022.
  • Gates Foundation opened 0 new positions and closed 0 in Q1 2022.
  • Gates Foundation's portfolio value fell 44% quarter-over-quarter to $186M.

Based on Gates Foundation's 13F filing for Q1 2022, filed 13 May 2022.